|
|||||
|
|
Switch from abiraterone plus prednisone to abiraterone plus dexamethasone at asymptomatic PSA progression in patients with metastatic castration-resistant prostate cancer |
|
| Authors: | Charlotte Fenioux Christophe Louvet Emilie Charton Francois Rozet Stanislas Ropert Dominique Prapotnich Eric Barret Rafael Sanchez-Salas Annick Mombet Nathalie Cathala Marie-Liesse Joulia Jean-Luc Molitor Julie Henriques Franck Bonnetain Xavier Cathelineau Mostefa Bennamoun |
| Affiliation: | 1. Department of Medical Oncology, Institut Mutualiste Montsouris, Paris, France;2. Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France;3. Department of Urology, Institut Mutualiste Montsouris, Paris, France;4. Department of Medical Oncology, Antony's Private Hospital, Antony, France |
| Abstract: | |
| Keywords: | abiraterone corticoid dexamethasone metastatic castration-resistant prostate cancer genitourinary tumours #PCSM #ProstateCancer |